Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 1
1988 2
1989 3
1991 3
1992 5
1993 4
1994 6
1995 4
1996 5
1997 1
1998 6
1999 6
2000 6
2001 5
2002 4
2003 1
2004 3
2005 3
2006 3
2008 1
2009 1
2010 2
2011 1
2012 2
2013 1
2014 1
2015 1
2016 3
2018 1
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, Bordes P, Cherubini A, Cruz-Jentoft AJ, Di Bari M, Friede T, Gorostiaga Ayestarán C, Goyeau H, Jónsson PV, Kashiwa M, Lattanzio F, Maggio M, Mariotti L, Miller RR, Rodriguez-Mañas L, Roller-Wirnsberger R, Rýznarová I, Scholpp J, Schols AMWJ, Sieber CC, Sinclair AJ, Skalska A, Strandberg T, Tchalla A, Topinková E, Tosato M, Vellas B, von Haehling S, Pahor M, Roubenoff R, Marzetti E; SPRINTT consortium. Bernabei R, et al. BMJ. 2022 May 11;377:e068788. doi: 10.1136/bmj-2021-068788. BMJ. 2022. PMID: 35545258 Free PMC article. Clinical Trial.
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans.
Jyväkorpi SK, Ramel A, Strandberg TE, Piotrowicz K, Błaszczyk-Bębenek E, Urtamo A, Rempe HM, Geirsdóttir Ó, Vágnerová T, Billot M, Larreur A, Savera G, Soriano G, Picauron C, Tagliaferri S, Sanchez-Puelles C, Cadenas VS, Perl A, Tirrel L, Öhman H, Weling-Scheepers C, Ambrosi S, Costantini A, Pavelková K, Klimkova M, Freiberger E, Jonsson PV, Marzetti E, Pitkälä KH, Landi F, Calvani R; SPRINTT consortium. Jyväkorpi SK, et al. Eur Geriatr Med. 2021 Apr;12(2):303-312. doi: 10.1007/s41999-020-00438-4. Epub 2021 Feb 13. Eur Geriatr Med. 2021. PMID: 33583000 Free PMC article. Clinical Trial.
Antiviral Agents From Fungi: Diversity, Mechanisms and Potential Applications.
Linnakoski R, Reshamwala D, Veteli P, Cortina-Escribano M, Vanhanen H, Marjomäki V. Linnakoski R, et al. Among authors: vanhanen h. Front Microbiol. 2018 Oct 2;9:2325. doi: 10.3389/fmicb.2018.02325. eCollection 2018. Front Microbiol. 2018. PMID: 30333807 Free PMC article. Review.
Probucol in long-term treatment of hypercholesterolemia.
Strandberg TE, Vanhanen H, Miettinen TA. Strandberg TE, et al. Among authors: vanhanen h. Gen Pharmacol. 1988;19(3):317-20. doi: 10.1016/0306-3623(88)90023-7. Gen Pharmacol. 1988. PMID: 3046993 Review.
Cohort Profile: The Helsinki Businessmen Study (HBS).
Strandberg TE, Salomaa V, Strandberg AY, Vanhanen H, Sarna S, Pitkälä K, Rantanen K, Savela S, Pienimäki T, Huohvanainen E, Stenholm S, Räikkönen K, Tilvis RS, Tienari PJ, Huttunen J. Strandberg TE, et al. Among authors: vanhanen h. Int J Epidemiol. 2016 Aug;45(4):1074-1074h. doi: 10.1093/ije/dyv310. Epub 2015 Dec 24. Int J Epidemiol. 2016. PMID: 26705307 No abstract available.
Percutaneous coronary interventions in Europe 1992-2003.
Cook S, Togni M, Walpoth N, Maier W, Muehlberger V, Legrand V, Milicic D, Zambartas C, Zelizko M, Madsen JK, van Buuren F, Lòpez-Palop R, Peeba M, Koskenkorva J, Vanhanen H, Lablanche JM, Lazaris I, Géza F, Eyjolfsson K, Kearney P, Piscione F, Erglis A, Navickas R, Beissel J, Channam R, Koch K, Deleanu D, Melberg T, Witkowski A, Pereira H, Reho I, Fridrich V, Zorman D, Nilsson T, Oezmen F, Ludman P, Meier B. Cook S, et al. Among authors: vanhanen h. EuroIntervention. 2006 Feb;1(4):374-9. EuroIntervention. 2006. PMID: 19755208 Free article.
[ASA therapy or not?].
Strandberg T, Vanhanen H. Strandberg T, et al. Among authors: vanhanen h. Duodecim. 2002;118(6):557-9. Duodecim. 2002. PMID: 12232998 Finnish. No abstract available.
88 results